Our latest article “Strict Procedures vs Urgent Needs: Is it possible to be equal to the occasion?” by Nihan Bacanak, Can Aksoy ve Bengüsu Güvendi is published on Lexology.
As known, pharmaceutical products for human use can in principle only be placed on the market upon obtaining a licence for the specified indications for which the product is allowed to be used. On the other hand, as experienced during the COVID-19 pandemic, not being able to access pharmaceutical products particularly in cases of emergency where a licensed product is unavailable can lead to aggrievements and the lengthiness of the process of obtaining a licence for a pharmaceutical product can cause additional problems. Hence it is of utmost importance to properly set a balance between satisfying the urgent needs of patients in an efficient manner and safely placing the products on the market. Various methods enabling patients to access unlicensed products are available under Turkish law. Amongst these methods which are briefly described below, named patient programme and off-label use have enabled rapid actions to be taken in particular during the COVID-19 pandemic.
You may reach the article here.
Share
Related persons
You can contact us for detailed information.

Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
6 July 2026
Legal developments regarding herbal medicinal products, foods for special medical purposes and medical devices
The Regulation on Aromatherapeutic Products and the Regulation on Medicinal Herbal Teas, together with the amendments to the Regulation on…
6 July 2026
“Made in EU” and Türkiye what the net-zero industry act means for business
In March 2026, the European Commission published a draft of the Net-Zero Industry Act, a legislative proposal that carries significant…
29 June 2026
A new era of specialised courts for challenges against Turkish regulatory authorities’ decisions
A significant reform has been introduced regarding the judicial review of decisions issued by regulatory authorities in Türkiye.
23 June 2026
Turkish courts and artificial intelligence — Part I: Istanbul commercial court expressly discloses use of AI in drafting reasoned judgment
The case arose from a consultancy agreement concluded in 2015 between a Netherlands-domiciled consultancy firm and an Istanbul-based…
16 June 2026
Turkish lock-up undertakings in public offerings
Various mechanisms are employed in public offering processes to establish investor confidence and preserve the stability of share prices.
4 June 2026
Recent tax developments: presidential decree No. 11257 and law No. 7582
A significant package of tax measures has recently taken shape in Türkiye. Presidential Decree No. 11257, published in the Official Gazette…